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Abstract
Background: We present a multilevel, agent based, in silico model that represents the dynamics
of rolling, activation, and adhesion of individual leukocytes in vitro. Object-oriented software
components were designed, verified, plugged together, and then operated in ways that represent
the molecular and cellular mechanisms believed responsible for leukocyte rolling and adhesion. The
result is an in silico analogue of an experimental in vitro system. The experimentally measured,
phenotypic attributes of the analogue were compared and contrasted to those of leukocytes in
vitro from three different experimental conditions.
Results: The individual in silico dynamics of "rolling" on simulated P-selectin, and separately on
simulated VCAM-1, were an acceptable match to individual in vitro distance-time and velocity-time
measurements. The analogues are also able to represent the transition from rolling to adhesion on
P-selectin and VCAM-1 in the presence of GRO-α chemokine. The individual in silico and in vitro
behavioral similarities translated successfully to population level measures. These behavioral
similarities were enabled in part by subdividing the functionality of the analogue's surface into 600
independent, "cell"-controlled, equally capable modules of comparable functionality.
Conclusion: The overlap in phenotypic attributes of our analogue with those of leukocytes in
vitro confirm the considerable potential of our model for studying the key events that determine
the behavioral outcome of individual leukocytes during rolling, activation, and adhesion. Our results
provide an important foundation and framework for future in silico research into plausible causal
links between well-documented, subcellular molecular level events and the variety of systemic
phenotypic attributes that distinguish normal leukocyte adhesion from abnormal disease-associated
adhesion.
Background
What molecular-level events determine the behavioral
outcome of individual leukocytes during rolling, activa-
tion, and adhesion to venular surfaces? These processes
are necessary steps for the proper recruitment of leuko-
cytes from circulating blood to sites of inflammation.
Once at the target site, leukocytes help destroy pathogens
and decompose damaged tissue. However, inflammatory
mechanisms are also associated with diseases such as
asthma, rheumatoid arthritis, multiple sclerosis, and
atherosclerosis. Such diseases can be characterized by
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inappropriate leukocyte recruitment and the misdirected
actions of leukocytes towards healthy host-tissue [1].
Rolling and adhesion following attachment are two of the
least complicated of many individual leukocyte behaviors
that have been studied in vitro using flow chamber assays.
Those behaviors are by no means deterministic. A striking
feature of such studies is that cell behavior is heterogene-
ous: individual cell behaviors under identical conditions
can be quite different. No two cells behave the same, yet
collective behaviors are robust and fall reliably within nar-
row ranges. Rolling, for example, exhibits an irregular,
jerky stop-and-go pattern along with highly fluctuating
rolling velocities [2]. Additionally, in the presence of
chemokine, only a fraction of a leukocyte population will
adhere firmly [3].
A goal in systems biology research is to understand link-
ages from molecular level events to system phenotype:
link genotype to phenotype. That task requires having
plausible, adequately detailed design plans for how com-
ponents (single and composite) at various system levels
are thought to fit and function together. Ideas about such
plans can be induced from the results of experiments.
Experimentation is then used to reconcile different design
plan hypotheses. More is needed, however, to actually
demonstrate that a design plan is functionally plausible,
which is very different from demonstrating that it is con-
sistent with measured behaviors. The former requires that
one assemble individual components according to a
design, and then show that the constructed device, an ana-
logue – on its own – exhibits behaviors that match those
observed in the original experiment.
Building such analogues in silico is now feasible. To make
it practicable, we need multilevel modeling and simula-
tion methods that make it easy to test, reject, and refine
many candidate design plans. In this report, we describe
discovering, building, and testing aspects of a simple yet
plausible design plan. That achievement is an essential
step toward the long-term biological goal for this project:
develop scientifically useful, validated simulations of leu-
kocyte recruitment under physiological and pathophysio-
logical conditions. We use the synthetic modeling
approach. Object-oriented software components were
designed, verified, plugged together, and then operated in
ways that represent the mechanisms and processes
believed responsible for leukocyte rolling and adhesion.
The result is an analogue of an in vitro experimental sys-
tem. An analogue refinement method is used in which
experimentally measured phenotypic attributes are itera-
tively compared and contrasted to those of leukocytes in
vitro.
During leukocyte rolling, the initial interactions between
leukocyte and surface are primarily mediated by the selec-
tin family of receptors and their respective carbohydrate
ligands found on the membranes of both the leukocytes
and endothelial cells. Transient selectin-ligand interac-
tions enable rolling. Leukocyte arrest is mediated by the
integrin receptor family. Integrins exist largely in nonad-
hesive states to prevent leukocytes from sticking non-spe-
cifically to blood vessels. As leukocytes roll along the
venular surface, they use their chemokine receptors to
detect immobilized chemokines on activated endothelial
cells. Upon detection, intracellular signaling events trigger
integrin conformational changes, increasing integrin-lig-
and affinity. High affinity integrins enable the leukocytes
to firmly adhere to the vessel wall or flow chamber surface
[4]. Signaling through chemokine receptors can also
induce lateral movement and clustering of integrins
within the membrane to promote leukocyte adhesion
[5,6]. In addition, the engagement of some selectins and
integrins with their ligands can initiate various activation
signals to enhance adhesion [7,8].
With their Adhesive Dynamics simulations, Hammer and
co-workers have elegantly demonstrated how challenging
it can be to generate similar rolling characteristics in silico
when using physical and mechanical representations
combined with traditional modeling formalisms [9-11].
In their models, leukocytes are represented as solid
spheres decorated with rod-like "microvilli" containing
receptors at their tips. Using a Monte Carlo algorithm for
the determination of receptor-ligand interactions, they
have successfully produced a jerky stop-and-go pattern
similar to that observed for rolling leukocytes. Such mod-
els can be fragile to context. When they target specific phe-
nomena and constrain their use to account for specific sets
of data, it becomes difficult to extend the model to differ-
ent experimental circumstances or to help explain differ-
ent phenomena or particular examples of individual
behavior. It becomes difficult to explore potential mecha-
nistic differences between individual cell behaviors, for
example. Are there alternative modeling and simulation
approaches that are less susceptible to such problems? The
multilevel approach described here was selected in part to
help circumvent those problems.
A measure of a particular behavior is a phenotypic
attribute. Table 1 lists several targetable attributes. The
greater the similarity between the measured behaviors of
our in silico white blood cells (ISWBCs) and the in vitro
attributes of interest, the more useful that in silico system
will become as a research tool and as an expression of the
coalesced, relevant leukocyte knowledge. An early goal
has therefore been to produce increasing overlap between
ISWBC behaviors, properties, and characteristics, and the
in vitro properties listed in Table 1. Once that is achieved,BMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
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we can look forward to simulating behaviors that are
more complicated, such as those associated with the
above listed diseases, and predicting the consequences of
interventions. The phenotypic overlap sought and a
method for extending it are illustrated and described in
Figure 1. To achieve that overlap we need to enable
ISWBCs to mimic an expanding variety of leukocyte
attributes. Merging lessons from the literature and related
simulation projects [12] with those learned during the
early stages of this project, along with identifiable require-
ments that must be met in order to achieve the insights
referred to above, we arrived at ten capabilities that the
envisioned ISWBCs should exhibit.
1. Individual behavior: the models need to be capable of
accurately representing the unique individual behavior
patterns typical of leukocytes observed in vitro and in
vivo.
2. Multilevel1: it needs to be easy to increase or decrease the
number of model levels and alter communications
between levels.
3. Mapping: there are clear mappings between leukocyte
and ISWBC components and their interactions because in
silico observables have been designed to be consistent
with those of the referent in vitro flow chambers.
4. Turing test: when an ISWBC and the simulated flow
chamber are each endowed with a specified set of ligands,
the measures of ISWBC behaviors during simulations
should be, to a domain expert (in a type of Turing test),
experimentally indistinguishable from in vitro flow
chamber measurements; this requires that an ISWBC and
its framework must be suitable for experimentation.
5. Transparent: ISWBCs must be transparent. The details of
components and their interactions as the simulation
progresses need to be visualizable, measurable, and acces-
sible to intervention.
6. Articulate: the components articulate. It must be easy to
join, disconnect, and replace ISWBC components within
and between levels, including the simulated experimental
context.
7. Granular2: because of how ISWBCs are componentized,
it should be relatively simple to change usage and
assumptions, or increase or decrease detail in order to
meet the particular needs of an experiment, without
requiring significant re-engineering of the in silico system.
8. Reusable: an ISWBC (and its components) must be reus-
able for simulating behaviors in different experimental
conditions, in vitro and in vivo, and when different sets of
ligands, chemokines, and chemical reagents (e.g., anti-
bodies) are considered.
Table 1: Targetable phenotypic attributes of leukocytes in vitro: an abridged list
Phenotypic Attribute Figure/Table Reference
Set A: initially targeted attributes
Jerky stop and go movement Figures 5, 6 [16]
Highly fluctuating rolling velocities Figure 7A [15]
Larger rolling velocities observed at higher shear rates Figures 6A, 8 [50]
Smaller rolling velocities at higher ligand substrate densities Not Shown [50]
Set B: additional attributes added to targeted set
ROLLINGa velocities on PSELECTINa match reported values Table 6 [50]
Small number of bonds within the contact zone, e.g., within 2–20 Table 6 [19], [20]
Distance-time and velocity-time data for ROLLINGa on aPSELECTIN/VCAM1 are indistinguishable from reported 
data
Figures 6, 7, 8 [15], [16]
Chemokines induce adhesion within seconds Figure 10 [3]
Leukocyte spreading during firm adhesion Figure 10 [51]
Set C: future, targetable attributes
Ligand-Receptor mobility, valency (clustering), and trafficking N/A [5], [6], [52]
Change in contact surface area with increasing shear force N/A [25], [53]
Shear threshold effect for selectins (minimum shear required for rolling) N/A [50]
Effect of inhibitors to signaling molecules on cell arrest (pertussis toxin (PTx)-sensitive G proteins, 
phosphoinositide 3-kinase, p38 mitogen-activated protein kinase)
N/A [3]
Intracellular calcium mobilization N/A [3]
During early development of the ISWBCs attention focused primarily on Set A. Once satisfactory simulations began to be achieved, the targeted 
attributes were expanded to those in Set B. Final validations focused on the combined set.
a We use SMALL CAPS when referring to the in silico components (see Table 3), features, measurements, and events.BMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
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9. Embeddable: ISWBCs must be constructed so that they
can function as components of larger, whole organism or
tissue models, and eventually represent the full range of
trafficking attributes.
10. Discrete interactions: to enable the above capabilities,
an ISWBC and its framework must use discrete interac-
tions that explicitly show the relation between compo-
nents.
In this report, we describe significant early progress in
building and experimenting with ISWBCs designed to
exhibit these capabilities. To achieve them, the ISWBC
needed to be distinct from cellular automata (CA) mod-
els, including lattice-gas, Ising, and Potts models, in its
combination of spatial and non-spatial interactions
between components. Some components (agents, as
described in Methods) interact via a regular grid as in a
CA. However, they also interact directly or through other
data structures like lists.
We initially focused on the attributes in Set A of Table 1.
We then iteratively revised the ISWBC to mimic the com-
bined attributes in Sets A and B. Each ISWBC was autono-
mous. Because the preceding capabilities are oriented
toward the evaluation of plausible mechanisms, less
emphasis is placed on condition-dependent, precise pre-
diction. Behaviors were observed over a range of condi-
tions without modeler intervention. Simulation results
were heterogeneous and non-deterministic. Importantly,
when simulating populations of leukocytes under differ-
ent experimental conditions (combinations of substrate
molecules), the in silico system generated quantitative
population-level data that were similar to data from in
vitro experiments. The results have provided an important
foundation and framework for future modeling and sim-
ulation studies capable of exploring plausible causal links
between well-documented, subcellular molecular level
events and the variety of system level phenotypic
attributes that accurately reflect leukocyte rolling and
arrest under a wide range of conditions.
Results
To avoid confusion hereafter and clearly distinguish in sil-
ico components, features, measurements, and events from
their in vitro counterparts, such as leukocyte, adhesion,
bond, etc., we use SMALL CAPS when referring to the in
silico components. Examples are provided in Table 2.
The system described below is the product of iterative
refinement of predecessor analogues that focused initially
on Set A in Table 1 and later on Sets A and B. Refinement
followed the process illustrated in Figure 1B. The in vitro
experimental results that we chose to designate as targeted
attributes focused on leukocyte ligands PSGL-1, VLA-4
integrin, and CXCR-2 chemokine receptor in addition to
their respective substrate ligands: P-selectin, VCAM-1, and
GRO-α chemokine. This group represents a minimal set of
ligand-binding pairs sufficient for allowing leukocytes to
roll, become activated, and firmly adhere in parallel plate
flow chambers [3,15-18]. Table 3 lists the leukocyte recep-
An illustration of similarities of in silico and in vitro model  systems Figure 1
An illustration of similarities of in silico and in vitro 
model systems. An abstract, Venn-like diagram depicts 
overlapping sets of similar features of in silico and in vitro 
models. The larger circle is a set of observable, measurable, 
phenotypic attributes of the experimental in vitro flow cham-
ber system. Attention is focused on selected aspects of the 
system, e.g., leukocyte interactions with the flow chamber 
surface. (A) a: each small shaded domain represents experi-
mental measures of a specific in vitro characteristic or prop-
erty such as distance rolled. The degree of shading illustrates 
different levels of experimental and measurement uncer-
tainty. t: these are members of the set of targeted in vitro 
attributes that the in silico model is expected mimic. The 
shaded circle contains the much smaller set of observable, 
measurable attributes of a foundational in silico analogue, 
such as the ISWBC. (B) The sketch illustrates the systematic, 
sequential extension of the foundational analogue's attributes 
to improve model-referent phenotype overlap. Circle #1: 
The set of attributes targeted by the ISWBC in A (the foun-
dational analogue). Circle #2 (shaded): The targeted 
attributes (represented by circle #1) have been expanded to 
include two new attributes; however, ISWBC #1 fails to gen-
erate behaviors similar to the two newly targeted attributes, 
resulting in its invalidation. A copy of the ISWBC is iteratively 
refined (without losing or breaking the original behaviors) by 
adding new detail only as needed (or by replacing an atomic 
component with a composite component) until successful 
coverage of the expanded set of targeted attributes is 
achieved. Oval #3 (dotted): The analogue represented by cir-
cle #2 is to be improved: one new attribute is added to the 
set of targeted attributes in 2, and the process just described 
is repeated.BMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
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tors represented, their corresponding ligands, and the
behaviors they support.
The system illustrated in Figure 2A has been designed to
represent an in vitro flow chamber (Figure 2B). The exper-
iments using it are analogous to those performed using an
in vitro system (four examples are listed below). The SUR-
FACE of the simulated chamber is "coated" with a uni-
form density of the LIGANDS of interest. A LIGAND is a
component that represents a number of ligands found
within a discrete portion (see MEMBRANE UNIT below)
of a leukocyte membrane or the flow chamber surface.
While in the FLOW CHAMBER, LEUKOCYTES use their
LIGANDS to interact and form BONDS with the SUB-
STRATE-COATED SURFACE. Each BOND is an in silico
analogue of a single ligand-ligand bond. Those interac-
tions are recorded and measured. Under the influence of
simulated flow, BONDS at the rear of the CONTACT
ZONE experience a simulated cumulative tensile force
due to shear; it is controlled by the parameter RearForce.
We learned from earlier, simpler analogues that a
dynamic decisional process of the type diagrammed in
Figure 3, was needed at two levels: LEUKOCYTE/MEM-
BRANE and MEMBRANE UNIT. As described in Methods,
the SURFACE, LEUKOCYTE, and MEMBRANE are sepa-
rate objects. A MEMBRANE UNIT is an analogue of a func-
tional unit of leukocyte membrane within the CONTACT
ZONE. There is a corresponding SURFACE UNIT. The
number of UNITS is a discretization decision. How fine or
course does the discretization (granularity) need to be in
order to avoid discretization artifacts and achieve the tar-
geted behaviors? As shown below, a level of discretization
is reached at which an acceptable match to targeted behav-
iors is achieved; further increasing granularity does not
improve the quality of the match.
We investigated the ISWBC's ability to represent in vitro
measures of rolling and adhesion by comparing simula-
tion results with data from three different flow chamber
experiments:
(1) Smith et al. [16] and Park et al. [15] observed human
neutrophils rolling on various densities of P-selectin and
under varying wall shear rates.
(2) Alon et al. [17] recorded human lymphocyte-rolling
trajectories on VCAM-1 in the presence of increasing wall
shear rates at fixed time intervals.
(3) Monocyte rolling and adhesion on P-selectin and/or
VCAM-1 in the presence or absence of GRO-α chemokine
was studied by Smith et al. [3].
Simulating neutrophil rolling on P-selectin
The in vitro data suggests that leukocyte rolling is medi-
ated by small numbers of receptor-ligand bonds formed
within the contact zone. Mathematical model estimates of
this number range between two and twenty [19,20]. Sin-
gle bond events are believed to cause rolling behaviors
similar to what one might expect of a stochastic process.
There are two easily recognized manifestations: jerky stop-
and-go patterns and highly fluctuating rolling velocities
[2]. Given the importance of single bond events, each
ISWBC BOND maps to a single ligand-ligand bond. How-
ever, a LIGAND can map to more than one ligand mole-
cule.
Two observations considered together, pause times and
forward movement during rolling, required that the upper
limit for the mapping of simulation cycle to in vitro time
be about 1 simulation cycle = 0.1 seconds. Pause time
measurements, the first targeted attribute, were made over
a small range of shear values as reported by Smith et al.
[16] for human neutrophils rolling on a P-selectin-coated
surface. Using high-speed videomicroscopy with a small-
est resolvable step size of 0.5 μm, average pause times
were in the range of 0.1 to 0.16 seconds for shear stress
values of 0.5 to 2.0 dyn/cm2. Higher wall shear stress val-
ues caused shorter average pause times.
We defined LEUKOCYTE ROLLING as a sequence of at
least 10 simulation cycles during which a LEUKOCYTE
remained non-stationary on the SURFACE. During ROLL-
ING, ISWBCs used the relationship between LIGAND dis-
association probability and bondforce graphed in Figure
4A. Bondforce is an in silico analogue of the force experi-
enced by each BOND within the contact zone. When
parameterized according to Table 4, using the values listed
in Table 5 (part I-A), the simulation's smallest forward
Table 2: In vitro and in silico ligand counterparts, their class types, and their locations within the ISWBC
Ligand Molecule In Silico Model Component Object Class Location
PSGL-1 PSGL1 ADHESION MOLECULE MEMBRANE
P-selectin PSELECTIN ADHESION MOLECULE SURFACE
VLA-4 VLA4 INTEGRIN MEMBRANE
VCAM-1 VCAM1 ADHESION MOLECULE SURFACE
CXCR-2 CXCR2 CHEMOKINE RECEPTOR MEMBRANE
GRO-α GROA CHEMOKINE SURFACEBMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
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movement (ratcheting forward by one MEMBRANE
UNIT) maps to 1 μm, twice that of the videomicroscope
used by Smith et al. To be acceptably similar, given the dif-
ference in time resolution, the magnitude of average sim-
ulated pauses needed to be within 1 to 2 times the in vitro
values of 0.1 to 0.16 seconds, or between 0.1 and 0.32.
That was achieved when we specified 1 simulation cycle =
0.1 seconds in vitro. Figure 5 shows that at RearForce val-
ues of 0.2 through 0.5, the median PAUSE TIMES fell
within that range. We judged these results to be accepta-
ble. At a RearForce value of 0.1, the median PAUSE TIME
appeared to deviate slightly from this range. Future stud-
ies using a finer time resolution may yield results even
closer to the in vitro data, should that be needed.
Simulated distance-time measures for each RearForce con-
dition exhibited the characteristic jerky stop-and-go
movement (Figure 6A). Smith et al. reported trajectories
of human neutrophils rolling on P-selectin at a density of
25 sites/μm2 while under a wall shear stress of 2.0 dyn/
cm2. When using the ENVIRONMENT parameter values
from Table 5 (part I-B), simulations produced LEUKO-
CYTE trajectories that were experimentally similar to in
vitro data (Figure 6B).
Simulated velocity-time measures also showed that LEU-
KOCYTES exhibited fluctuating velocities similar to those
reported in the literature. Park et al. [15] observed human
neutrophils rolling on P-selectin at a density of 9 sites/
μm2 under a wall shear rate of 0.5 dyn/cm2. When we ran
simulations using ENVIRONMENT parameter values
from Table 5 (part I-C), we observed similar behavior: the
range of both LEUKOCYTE ROLLING velocity values and
distance values plotted in Figure 7 are similar to those
reported in [15]. The results clearly exhibit the essential
jerky stop-and-go movement and highly variable ROLL-
ING velocities that are characteristic of leukocytes rolling.
To further evaluate and validate LEUKOCYTE ROLLING,
we determined the average ROLLING velocity, the average
number of BONDS within the contact area, and the aver-
age number of BONDS at the rear of the LEUKOCYTE.
Table 6 shows results. Average ROLLING velocities fell
within ranges that have been reported for rolling on P-
selectin. Consistent with in vitro experimental data, aver-
age ROLLING velocity increased with increasing RearForce
values. The average number of BONDS within the contact
area and the average number at the rear of the LEUKO-
CYTES under all three RearForce conditions were consist-
ent with the estimated numbers stated above.
Experiments that simulate lymphocyte rolling on VCAM-1
VLA-4 is unique among the integrins, as it has been shown
to support leukocyte tethering and rolling. In flow cham-
bers coated with VCAM-1, a ligand for VLA-4, leukocytes
roll even in the absence of selectins or chemokines [3,17].
Competitive binding experiments determined that native
state VLA-4 has affinity constant values similar to those of
the selectins [21].
The goal of the second set of simulation experiments was
to show that ISWBC ROLLING behaviors are similar to
those of leukocytes rolling on VCAM-1 in the absence of
chemokine. Alon et al. observed human T-lymphocytes
rolling on different densities of purified VCAM-1 in flow
chambers [17] under increasing shear stress. Shear was
increased at fixed intervals resulting in increased leuko-
cyte rolling velocities. Using parameter values from Table
4 and Table 5 (part II), simulations generated LEUKO-
CYTE ROLLING trajectories that appeared indistinguisha-
ble to those reported by Alon et al (Figure 8). Average
ROLLING VELOCITIES were calculated for each RearForce
value. They were within the range of in vitro rolling veloc-
ities at each reported shear stress value (Figure 8, Insert).
Simulating monocyte rolling, activation, and adhesion on 
P-selectin and/or VCAM-1 in the presence or absence of 
GRO-α chemokine
Smith et al. [3] used a flow chamber to observe human
monocytes rolling and adhering on P-selectin and/or
VCAM-1 with or without immobilized GRO-α chemok-
ine: six different conditions were studied. During per-
fusion of leukocytes through the chamber, 30-second
recordings of five fields of view were taken along the
chamber length. The average number of rolling and
arrested cells was determined. Cells that remained immo-
bile for at least 20 seconds were considered arrested.
Using that same combination of in silico substrate ana-
logues, the ISWBC parameter space, constrained by the
already established parameter values in Table 5 (parts I
and II), was searched empirically for parameter sets that
would provide acceptable matches for all six experimental
Table 3: Leukocyte receptors, their corresponding ligands, and their allowed behaviors
Leukocyte Receptor Surface Receptor-Ligand Behaviors
PSGL-1 P-Selectin Rolling
VLA-4 Integrin VCAM-1 Rolling, Firm Adhesion
CXCR-2 Chemokine Receptor GRO-α Chemokine Activation
These three receptor-ligand pairs were chosen because together they are sufficient for enabling leukocytes to roll, become activated, and firmly 
adhere in vitro.BMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
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Sketches of in vitro and in silico experimental system components Figure 2
Sketches of in vitro and in silico experimental system components. (A) A LEUKOCYTE object is shown pulled away 
from the simulated flow chamber surface to which it was attached. The left arrow indicates ROLL direction; the three right 
arrows indicate SHEAR resulting from the simulated flow. The simulated flow chamber surface is discretized into independent 
units of function called SURFACE UNITS. The LEUKOCYTE'S MEMBRANE is similarly discretized into matching units of func-
tion called MEMBRANE UNITS: 600 total (20 × 30). The 8 × 10-shaded region on the SURFACE and on the underside of the 
LEUKOCYTE identifies the CONTACT ZONE. The UNITS within the CONTACT ZONES that are shaded differently indi-
cate different numbers of BONDS had formed between LIGAND-LIGAND pairs in overlapping UNITS; otherwise, no BONDS 
formed. ROLLING is the result of a sequence of forward ratchet events. One ratchet event is the result of one row of MEM-
BRANE UNITS being released at the rear of the CONTACT ZONE along with engagement of a new row of at the front of the 
CONTACT ZONE. One ratchet event maps to a leukocyte rolling 1 μm (relative to the flow chamber surface). (B) A shop 
drawing of a typical parallel plate flow chamber used for in vitro studies of leukocyte rolling and adhesion. A video microscope 
is used to record leukocyte behaviors. (C) MEMBRANE UNITS are illustrated. Each MEMBRANE UNIT is simulated using a 
software object functioning as a container. In this sketch, nine MEMBRANE UNIT containers are shown. All leukocyte mem-
brane functionality (relevant to these studies) within each UNIT is represented by three objects functioning as agents: PSGL1, 
VLA4 and CXCR2 (illustrated as spheres). The number of leukocyte ligands being represented by each is typically different 
from UNIT to UNIT, as illustrated by the numbers on the spheres. That number is specified for each simulation using parame-
ter values from Table 3.BMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
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The decisional process for the LEUKOCYTE MEMBRANE and each MEMBRANE UNIT during a simulation cycle Figure 3
The decisional process for the LEUKOCYTE MEMBRANE and each MEMBRANE UNIT during a simulation 
cycle. (A) The LEUKOCYTE steps through its decisional process only once during a simulation cycle. At the start of the cycle, 
the MEMBRANE instructs all MEMBRANE UNITS within the CONTACT ZONE to follow the decisional process in B. Once 
that process is complete, the MEMBRANE completes its process by selecting and following the one applicable action option. 
(B) A MEMBRANE UNIT is described and illustrated in Figure 2. The state of each depends on the properties of the three LIG-
AND objects contained within. During each simulation cycle, each MEMBRANE UNIT, selected at random, uses this decisional 
process to update its status relative to the SURFACE UNIT over which it is positioned. (C) The hierarchical organization of 
the ISWBC system is illustrated. There are six levels. An Experiment Agent exists within the system, but separate from the 
FLOW CHAMBER and LEUKOCYTE. It represents a researcher conducting wet-lab experiments: it measures and records 
events and behaviors during each simulation.BMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
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conditions. The LEUKOCYTE parameters from Table 4
and the ENVIRONMENT parameters from Table 5 (part
III) is such a set; it produced the results in Figure 9: the
data are averages from 20 sets of experiments containing
30 LEUKOCYTES each, with the duration of each run
being 300 simulation cycles (equivalent to about 30 sec-
onds). The number of ROLLING and adhering LEUKO-
CYTES for each batch were counted and averaged.
LEUKOCYTES that remained stationary on the SURFACE
for at least 200 simulation cycles (about 20 seconds) were
classified as ADHERED. Figure 9 shows that for all ligand
combinations simulated, the data matched that from in
vitro fairly well. There was even a similar significant
increase in the number of ADHERENT LEUKOCYTES on
PSELECTIN and VCAM1 due to the presence of GROA
CHEMOKINE, as was observed in vitro.
There are some notable discrepancies between the in silico
and in vitro data that are most likely a consequence of an
ISWBC being an abstract simplification of the more com-
plex reality. For example, in the absence of GRO-α chem-
okine, Smith et al. observed a small fraction of cells that
were able to adhere when rolling on VCAM-1 alone or
when VCAM-1 was co-immobilized with P-selectin. This
small fraction of adhering cells may be attributable to the
pre-activation of monocytes during cell isolation proce-
dures. We do not include any pre-activation effects, and
consequently do not observe any ADHERING LEUKO-
CYTES in the absence of GROA CHEMOKINE. By affect-
ing adhesion, the pre-activation of monocytes may
additionally affect the number of rolling leukocytes on
VCAM-1 substrate. We had such considerations in mind
when we adjusted parameter values, and so did not seek
the best possible match for any one condition. Instead, we
focused on obtaining behavioral similarities under differ-
ent conditions. By adjusting parameter values to bring in
silico and in vitro observations closer together for one
condition, we typically amplified discrepancies for other
conditions. If narrowing these discrepancies is deemed
among the important issues to be addressed next, then
our approach would be to include that specification
within the targeted attribute list in Set C of Table 1. To
achieve that goal, additional ISWBC detail would likely be
required. Literature guided, exploratory simulations
would be needed to identify candidate details. Fortu-
nately, because ISWBC design and construction are being
guided by the ten Capabilities listed in the Introduction,
such exploratory simulations are relatively easy to pursue.
Smith et al. also tracked individual monocytes under flow
to obtain rolling and arrest profiles [3]. They observed
that with P-selectin and VCAM-1 co-immobilized with
GRO-α chemokines, monocyte arrest occurred within a
few seconds. We simulated their protocol: we tracked
individual LEUKOCYTES that were able to transition from
FORCE dependence on BOND DISSOCIATION probability  and force dependence on bond dissociation rates Figure 4
FORCE dependence on BOND DISSOCIATION 
probability and force dependence on bond dissocia-
tion rates. (A) Shown is the relationship between bondforce 
and probability of BOND DISSOCIATION for each of the 
three LIGAND pairs within the CONTACT ZONE. The 
effects of shear on the ligand-ligand bonds that form at the 
rear of the leukocyte are simulated using bondforce. BONDS 
within the rear row of the CONTACT ZONE experience a 
bondforce that is calculated by dividing the RearForce, a unit-
less parameter representing the effects of shear, by the total 
number of BONDS within the rear row. During a simulation 
cycle, each MEMBRANE UNIT in the rear row uses the cur-
rent value of bondforce and the graphed relationship to calcu-
late a probability that each BOND will be broken during that 
cycle. All BONDS elsewhere within the CONTACT ZONE 
experience a bondforce value of 0. UNSTRESSED (bondforce 
value of 0) DISSOCIATION probabilities for PSGL1/PSELEC-
TIN, LOW-AFFINITY VLA4/VCAM1, and HIGH-AFFINITY 
VLA4/VCAM1 were chosen to be 0.14, 0.16, and 0.0035, 
respectively. (B) The in vitro force dependence of dissocia-
tion rates for P-selectin/PSGL-1 bonds (as reported in [15]) 
and the high affinity VLA-4/VCAM-1 bonds (as reported in 
[29]) are plotted for comparison to the analogue relation-
ships in A. The plotted values were taken from the fitted in 
vitro data: see Methods for details. The relationships in A are 
analogues of these experimentally determined relationships 
and are not meant to either match or fit that data. The disso-
ciation rates of the PSGL-1/P-selectin bonds as a function of 
force were determined by experiments using PSGL-1-coated 
microbeads rolling on a P-selectin substrate in a parallel plate 
flow chamber [15]. The dissociation rates for the VLA-4/
VCAM-1 complex, described in Methods, were calculated 
from data obtained using single-molecule dynamic force spec-
troscopy [29]. The force dependence of dissociation rates 
for low affinity VLA-4/VCAM-1 data was not reported. We 
assumed that it is similar to PSGL-1/P-selectin relationship in 
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Table 4: Model parameter values for the LEUKOCYTE MEMBRANE and LIGANDS along with corresponding in vitro values
Parameter Name Description Model Parameter Value Experimental Value Reference
LeukTotalWidth LEUKOCYTE MEMBRANE width (in the y [east-west] dimension) 20 MEMBRANE UNITS Avg. Human Leukocyte 
Diameters (μm): 
Lymphocyte: 6.2; Neutrophil: 
7; Monocyte: 7.5
[48]
LeukTotalLength LEUKOCYTE MEMBRANE length (in the x [north-south] dimension) 30 MEMBRANE UNITS
LeukExposedWidth CONTACT ZONE width (in the y dimension) 8 MEMBRANE UNITS NA NA
LeukExposedLength CONTACT ZONE length (in the x dimension) 10 MEMBRANE UNITS NA NA
PSGL1DensityMean ± 
PSGL1DensitySTDev
Mean number of PSGL-1 molecules (± SD) represented by 
each PSGL1 agent
Experiment 1: Neutrophils 150 ± 5a molecules ~18,000/Human Neutrophil [54]
Experiment 3: Monocytes 150 ± 5b molecules N/A N/A
VLA4DensityMean ± 
VLA4DensitySTDev
Mean number of VLA-4 molecules (± SD) represented by 
each VLA4 agent
Experiment 2: T-lymphocytes 45 ± 5 molecules 3,000/Human T-Lymphocyte [55]
Experiment 3: Monocytes 60 ± 5 molecules 6,000/Human Monocyte
CXCR2DensityMean ± 
CXCR2DensitySTDev
Number of CXCR-2 molecules (± standard deviation) represented by each CXCR2 agent 1 ± 0 molecules NA NA
VLA4MaxPercHighAff Maximum percent of VLA-4 integrins on the leukocyte membrane that can be induced into a high 
affinity statec
12.5% 10% [49]
Pon (PSGL1-
PSELECTIN1)
Probability of forming a PSGL1-PSELECTIN1 BOND 0.001 NAd [56]
Pon (LOW AFFINITY 
VLA4-VCAM1)
Probability of forming a LOW AFFINITY VLA4-VCAM1 BOND 0.001 NAd [55]
Pon (HIGH AFFINITY 
VLA4-VCAM1)
Probability of forming a HIGH AFFINITY VLA4-VCAM1 BOND 0.005 NAd [55]
Pon (CXCR2-GROA) Probability of forming a CXCR2-GROA BOND 1.0c NA NA
Poff (CXCR2-GROA) Probability of breaking a CXCR2-GROA BOND 1.0c NA NA
a PSGL1DensityMean ± PSGL1DensitySTDev parameter values used for simulating Experiment 1, neutrophil rolling, were originally 25 ± 5. They were changed to the values currently listed to more closely 
reflect the experimental values of PSGL-1 density reported in the literature. No significant differences were observed when using these new parameter values.
b Values for PSGL-1 sites/human monocyte were not found in the literature and were assumed to be similar to values reported for human neutrophils.
c See Methods.
d Pon and Kon are intended to map to aspects of the same in vitro phenomena. However, there is no direct mapping between these parameters because the parent models belong to fundamentally different 
classes [57].BMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
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ROLLING to FIRM ADHESION. We also observed that
FIRM ADHESION on PSELECTIN and VCAM1 in the pres-
ence of GROA CHEMOKINE was primarily mediated by
high affinity VLA4 and that it occurred within SECONDS.
Figure 10 shows an example LEUKOCYTE that is able to
ADHERE after ROLLING.
Discussions and conclusion
Setting the stage
A long-term biological goal for this project is to develop
scientifically useful, validated simulations of leukocyte
recruitment under physiological and pathophysiological
conditions. The envisioned LEUKOCYTES, functioning
within an analogue of the wet-lab context, will have many
behaviors, properties, and characteristics that mimic those
of referent in vitro and in vivo systems. Stated differently,
there will be similarities between leukocyte phenotype
and the "phenotype" of simulated leukocytes, as illus-
trated in Figure 1. The expectation is that increasing phe-
notype similarity will require, and can be achieved in part
through, similarities in design plan and in generative
mechanisms. Once they are achieved, the model will have
become a scientifically useful analogue.
Our approach to designing and building the envisioned
analogues is motivated by aspect-oriented software devel-
opment and the middle-out approach first suggested by
Brenner [22] and later detailed by Noble [23] for building
models of complex biological systems. We adapted and
merged these ideas in arriving at our working definition of
middle-out modeling. First, specify the biological features
under study (e.g., cell rolling and attachment to a surface).
Each feature becomes an aspect of a software device – an
archetype model. That archetype is iteratively transformed
into a functioning analogue of the referent in vitro biolog-
ical system. It is then validated and improved iteratively.
Following that approach, our first task was to pick a set of
properties, p1, p2, ... pj (within a hyperspace of mechanis-
tic properties) – around leukocyte rolling and adhesion in
vitro. We specified Set A, Table 1. We next asked what soft-
ware device could we implement to realize p1? How can
we realize p2, etc.? We then asked, how can we realize p1-
pj, all at the same time, using the same software device?
Getting answers to those questions required exploratory
modeling and simulation, occasionally using different
modeling and simulation support packages. The in silico
properties and the device we created to realize p1-pj
formed a foundational analogue, the above archetype
model, from which we intended to expand outward (up,
down, and even sideways) to establish a reductive hierar-
chy of components that could be used to identify impor-
tant systems biology principles.
Creating an analogue phenotype
The ISWBC is an abstract model of a leukocyte, and when
placed in an appropriate, simulated environment, it is
capable of mimicking a set of targeted characteristics. The
ISWBC exists within a system that is a model of an in vitro
flow chamber system (cells, media, the device in Figure
2B, atmosphere, etc.). The ISWBC is a multilevel compos-
ite model. The components are independent models of
their referent leukocyte or environment counterpart. For
example, the in silico component representing the MEM-
BRANE UNITS in a portion of the trailing edge of a ROLL-
ING LEUKOCYTE is itself a model of the corresponding
leukocyte feature.
The envisioned relationship between measured LEUKO-
CYTE behaviors and corresponding in vitro measures is
illustrated in Figure 1. Pictured are overlapping (but not
intersecting) sets. One set (Figure 1, large circle) contains
the results of experiments that measured specific pheno-
typic attributes, properties, or characteristics of leukocytes
in vitro (e.g., all three sets in Table 1). The smaller sets
contain the results of simulation experiments that meas-
ure corresponding in silico phenotypic attributes, proper-
ties, or characteristics (such as Set A, Table 1). Our
motivating hypothesis has been that, when attention is
focused on the same features, and the measured behaviors
of the two sets are similar, then there may also be useful
similarities in the generative mechanisms of the two sys-
tems. Those similarities can be explored by iterative test-
ing and refinement of the analogue coupled with related
wet-lab experiments. An example: distance traveled by a
LEUKOCYTE in silico (or a leukocyte in vitro) under vari-
ous simulated (or actual) shear stresses. We cannot expect
these measurements to overlap completely or even have
the same units. Observations on behavior similarity can
be used simultaneously to eliminate invalid model fea-
tures and identify gaps in our knowledge of the experi-
mental in vitro system.
The first step in transitioning from an archetype to an
improved LEUKOCYTE was to thoroughly document the
in silico properties and characteristics of the former. By
doing so, we improved insight into its strengths and weak-
nesses. The next step was to obtain increasing overlap with
measures of in vitro attributes. That was done systemati-
cally by iteratively revising together the hypothesis and
the analogue by following the five steps below. An exam-
ple hypothesis: the current analogue can acceptably simu-
late the first two attributes [p1, p2,] in Set A, Table 1.
Figures 7 and 8 are examples of successful simulations. We
begin the next iterative cycle with step 1.
1) Select an additional in vitro property or characteristic
that is related to those already in the target set, and for
which wet-lab experimental observations are available,BMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
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such as the third property in Table 1. Identify the addi-
tional property as p3.
2) Add p3 to the targeted set, yielding an expanded set [p1,
p2, p3], as illustrated by 2 in Figure 1B.
3) Determine if addition of the new attribute invalidates
the current analogue, and if so, why. If not, repeat step 2.
4) Revise the model iteratively, possibly by adding mech-
anistic detail, until the measured phenotypic attributes of
the revised analogue are sufficiently similar to [p1, p2, p3].
5) The next iterative cycle repeats steps 1–4 with p4, etc.
Our approach to achieving an envisioned ISWBC was
strongly influenced and constrained by the ten capabili-
ties listed in the Introduction. We reasoned that to achieve
our long-term goal it would be essential for future ISWBC
descendents to exhibit those capabilities.
Design
The conceptual model of the referent system, which is
fundamental to the design of the in silico model, is as fol-
lows. Functionalities within the leukocyte membrane are
grouped into a large number of similarly capable modu-
lar, functional units. Leukocyte rolling in vitro involves a
balance between the hydrodynamic force exerted by fluid
flow and the resistant forces resulting in part from tran-
sient bonds being formed between the leukocyte and the
substrate. Shear force coupled with random events causes
bonds to break at the rear of the contact zone. Bonds
formed within the contact zone are by nature transient
and will dissociate even in the absence of a tensile force.
Boxplot of measured PAUSE TIMES for LEUKOCYTES  ROLLING on PSELECTIN at various RearForce values Figure 5
Boxplot of measured PAUSE TIMES for LEUKO-
CYTES ROLLING on PSELECTIN at various Rear-
Force values. At each RearForce value, average PAUSE TIME 
was recorded from 60 simulations that had at least 10 
INTERACTIONS (pauses). In vitro, higher values of wall 
shear stress lead to shorter pause times. This data shows 
that higher RearForce values also lead to shorter LEUKO-
CYTE pause times. White circles: median pause time value. 
Box: lower and upper quartiles. Whiskers: minimum and 
maximum pause time values.
Table 5: Experimental values for the three in vitro flow chamber environments and the corresponding parameter values used for each 
of the three simulated experimental conditions
In Vitro Values ISWBC Values
Experiment Shear (dyn/cm2) Substrate Molecule Site density/Plating 
concentration
Rear Force LIGAND LIGAND Density
I. Neutrophil Rolling on P -Selectin
A. Pause Time 0.5, 1.0, 2.0 P-selectin 9 sites/μm2 0.1–0.5 PSELECTIN 15 ± 5
B. Distance-Time 2 P-selectin 25 sites/μm2 0.5 PSELECTIN 25 ± 5
C. Velocity-Time 0.5 P-selectin 9 sites/μm2 0.1 PSELECTIN 15 ± 5
II. T-Lymphocyte Rolling on VCAM-1
Distance-Time 0.73 – 7.3 VCAM-1 15 μg/mLa 0.15–1.6 VCAM1 45 ± 5
III. Monocyte Rolling on P-selectin/VCAM- 1/GRO-α
Rolling and Adhesion 1 VCAM-1 100 ng/mLa 1 VCAM1 13 ± 5
P-Selectin 10 μg/mLa PSELECTIN 25 ± 5
GRO-α 5 μg/mLa GROA 3 ± 2
The FLOW CHAMBER SURFACE dimensions were fixed at 100 × 60 SURFACE UNITS. Each SURFACE grid space maps to approximately 1 μm2 
of effective flow chamber surface area. a Values listed in units of [μg/mL] are the concentrations of the solutions of receptors used to coat the 
parallel plate flow chamber surfaces and are not meant to represent the concentrations of receptors found on the parallel plate surface.BMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
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Only a few bonds need to be present at any time in order
to maintain a rolling interaction. In order to maintain that
interaction, broken bonds must be replaced by new ones
formed elsewhere within the contact zone.
The transition from rolling to adhesion is mediated by the
integrin receptors that, when induced into a high affinity
state, are capable of forming effective ligand interactions
that are sufficiently stable to withstand the hydrodynamic
fluid force. However, they exist natively in a low affinity
state and can only aid in supporting rolling interactions.
There are many hypothesized mechanisms of integrin
activation. We explored one of the simplest: a chemokine
receptor, upon binding to its chemokine ligand, induces a
local VLA-4 integrin molecule into a high affinity state.
The resulting high affinity integrins form stronger and
longer-lasting bonds with VCAM-1. Diffusion and cluster-
ing of VLA-4 integrins is also hypothesized to play a role
in firm adhesion. However, to keep things relatively sim-
ple at this early stage, we have not simulated those events.
Achievements
The ISWBC components have been verified, plugged
together, and operated in ways that may represent (at a
relatively high level) mechanisms and processes that
influence leukocyte rolling and adhesion. The approach
has allowed us to represent the spatial and discrete event
phenomena that are thought to occur during leukocyte
rolling, activation, and adhesion. It has allowed us to rep-
resent apparently stochastic elements within the system
that may play a vital role in determining leukocyte behav-
ior in vivo and in vitro. Our earliest archetype had a CON-
TACT ZONE comprised of 2 × 3 MEMBRANE UNITS (48
for the total MEMBRANE of the LEUKOCYTE). With it, we
failed to even approach the first two targeted attributes in
Set A, Table 1; we were unable to simulate the stochastic
fine structure present in the in vitro data because the dis-
cretization was too coarse. It is common to observe such
discretization artifacts during simulation development
when the granularity is too coarse. To better achieve the
targeted behaviors, we decreased the relative MEMBRANE
UNIT size (decreased granularity) to represent the CON-
TACT ZONE by 3 × 6 units and then in steps to the current
size of 8 × 10 units (600 UNITS for the total MEM-
BRANE). With each increase in granularity, simulated
results more closely mimicked the in vitro data, as judged
by inspection. We also explored even finer grained CON-
TACT ZONES, up to 20 × 30, without further gains in sim-
ilarity. Taken together, these results suggest that
membrane functionality within and adjacent to the con-
tact zone is distributed into many (from our results, about
80) equally capable, somewhat autonomous units.
Though the ISWBCs are relatively simple, we have demon-
strated that they can generate the targeted attributes under
three different experimental conditions. Traditional mod-
els typically focus on just one condition. ISWBCs mimic
the dynamics of leukocytes rolling separately on a P-selec-
tin or VCAM-1 substrate. In addition, they mimic the tran-
sition from rolling to adhesion on P-selectin and VCAM-
1 in the presence of GRO-α chemokine. Importantly,
when simulating populations of leukocytes under differ-
ent experimental conditions (combinations of substrate
molecules), the system generates quantitative population-
level data that are similar to data from in vitro experi-
ments.
One hypothesis of leukocyte activation suggests that leu-
kocytes roll along the vessel wall progressively engaging
with chemokine signals to reach a global activation
threshold. Once achieved, fully activated integrins can
then support firm adhesion. However, there is growing
support for an alternative hypothesis: leukocyte adhesion
induced by immobilized chemokines occurs via local and
spatially restricted signaling to nearby integrins. Our
results support the latter hypothesis. In an elegant study,
Shamri et al. [24] showed that leukocyte engagement with
chemokine locally and reversibly induced the β2 integrin,
LFA-1, into an intermediate affinity state that was essential
for interaction with ICAM-1 under flow conditions. Con-
currently, engagement with ICAM-1 induced the signaling
events needed to fully activate local LFA-1 to the high
affinity state needed to support firm adhesion. Because of
the modeling approach used (providing the ten capabili-
ties, etc.), it will be relatively easy for future descendents
of the ISWBCs to represent such fine-grained, cooperative
behaviors and spatially restricted events.
Appraisal of the model assumptions
We have simulated human leukocytes of slightly different
sizes (neutrophils, lymphocytes, monocytes), however we
kept the CONTACT ZONE the same for all simulations. It
has been observed that leukocytes of greater size have a
greater area of surface contact, and thus can form more
bonds that are adhesive. However, biomechanical analy-
sis shows that with increasing leukocyte size there is an
increase in the amount of force and torque experienced.
This higher magnitude is believed to translate to higher
forces experienced by bonds. Cozen-Roberts [25] pre-
sented an analysis that was verified in vitro, which pre-
dicted that the disruptive force increases faster than the
pro-adhesive effect of increased contact area. Rather than
changing the dimensions of the contact area when simu-
lating experiments with different leukocyte types and
sizes, we fixed that dimension and compensated by using
greater RearForce values to represent the same shear force
when simulating larger leukocytes (see Table 5).
The conceptual model above is widely accepted for neu-
trophils. However, it is not entirely known how well itBMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
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applies to other leukocyte types, such as lymphocytes and
monocytes. Varying receptor types and densities found on
the different leukocyte types may be a factor contributing
to differing mechanisms of adhesion. For example, lym-
phocytes and monocytes express basal levels of VLA-4
integrins sufficient to support rolling [17]. In contrast, it
has been shown that transmigration across endothelium
or exposure to chemotactic stimuli is necessary to induce
expression of VLA-4 integrins on human neutrophils [26].
Therefore, rolling and adhesion through the VLA-4
integrin may require additional or different mechanisms
for neutrophils than for lymphocytes and monocytes. Our
objective during this project was not to construct a com-
prehensive model of rolling, activation, and adhesion for
all leukocyte types. However, when simulating monocyte
rolling and adhesion, we assumed that monocytes and
neutrophils share similar rolling characteristics on P-
selectin. Likewise, we assumed that the characteristics of
monocyte rolling on VCAM-1 are similar to those for lym-
phocytes. The only difference was presumed to be the
densities of each receptor type found on each leukocyte
type. Parameter values representing the densities of the
VLA-4 integrins for lymphocytes in experimental condi-
tion 2 and monocytes in experimental condition 3 were
different to reflect the different VLA-4 density values
reported in the literature. Values for PSGL-1 sites/human
monocyte were not found in the literature and were
assumed to be similar to values reported for human neu-
trophils.
Comparison to other leukocyte rolling and adhesion 
models
The discrete-time models used in the Adhesive Dynamics
simulations by Hammer and co-workers are the most
developed models of leukocyte rolling and adhesion to
date [9-11]. Leukocytes in their models are idealized as
solid spheres decorated with rod-like microvilli contain-
ing receptors at their tips. Their simulations have allowed
them to explore the molecular properties of adhesion
molecules, such as reaction rates and bond elasticity, and
how these properties may relate to macroscopic behavior
such as rolling and adhesion [9,11].
In their simulations, the position of the cell is determined
at each time step from the net force and torque on the cell
using a hydrodynamic mobility function for a sphere near
a plane wall in a viscous fluid. The net force and torque
acting on the cell from bonds, fluid shear, steric repulsion,
and gravity are calculated. When calculating the forces on
the sphere due to fluid shear, their model uses the Gold-
man equation [27]: the amount of force a sphere experi-
ences from an applied shear force is calculated by
assuming that the sphere is solid. At each time step in the
Adhesive Dynamics simulation, positions of bonds on the
spherical particle are tracked enabling the authors to cal-
culate the forces that each bond experiences.
It was not our intention to discover ISWBC parameteriza-
tions that would yield simulation results that tightly fit
specific sets of experimental data. Our approach has been
focused on simulating a targeted set of system-level prop-
erties (Figure 1). Therefore, we did not, for example,
attempt an explicit mapping between the shear force and
the amount of force experienced by bonds at the rear of
the leukocyte. Leukocytes are notoriously deformable and
therefore we elected to avoid a mapping such as the Gold-
man equation. In addition, the mapping from the force
on the cell to the force on the rear bonds can be quite
complex, as PSGL-1 and VLA-4 are both ligands that are
concentrated at the tips of stretchy and heterogeneous
microvilli. It should be noted that shear stress for selectin
tethers at the rear of neutrophils have been estimated pre-
LEUKOCYTES ROLLING on PSELECTIN exhibit the charac- teristic jerky stop-and-go pattern of leukocyte rolling in vitro Figure 6
LEUKOCYTES ROLLING on PSELECTIN exhibit 
the characteristic jerky stop-and-go pattern of leuko-
cyte rolling in vitro. (A) Examples are graphed for dis-
tance-time plots for a single ROLLING LEUKOCYTE studied 
in each of the indicated five RearForce conditions using the 
ENVIRONMENT parameter values in Table 5 (part I-A). (B) 
Solid line: values of a single leukocyte trajectory as reported 
in [16]. Open circles: an example LEUKOCYTE trajectory 
from simulations that used the ENVIRONMENT parameter 
values in Table 5 (part I-B).BMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
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viously using the Goldman equation to be 124 ± 26 pN
per dyn/cm2 [28].
To account for the effect of an applied force on the kinetics
of bond dissociation, Hammer and co-workers have
employed both the Bell model and Dembo Hookean
Spring model (see [2]). The Bell Model predicts bond dis-
sociation rate as a function of applied force, whereas the
Dembo model treats bonds as Hookean springs and
relates dissociation rate to the length of the stretched
bond. Use of a similar fine-grained representation of
bond dissociation may have yielded more precise simula-
tion results, but that level of resolution and precision was
not needed to meet the simulation objectives in Table 1.
Rather, we used a simple model to relate the probability
of bond dissociation with bond force (Figure 4A); it was
motivated by in vitro experiments by Park et al. [15], and
Zhang, et al. [29]. Because the time resolution within the
ISWBC is low (a tenth of a second), using the linear
approximations in Figure 4A proved reasonable: at small
bond force values, we assumed a linear relationship
between the probability of bond dissociation and bond
force. At larger bond force values, we reasoned that the
Comparison of in silico and in vitro instantaneous velocity  data Figure 7
Comparison of in silico and in vitro instantaneous 
velocity data. (A) Dotted trace: a leukocyte rolling on P-
selectin in vitro as reported in [15]. Gray, shaded traces: two 
simulations of a LEUKOCYTE ROLLING on PSELECTIN 
using ENVIRONMENT parameter values from Table 5 (part 
I-C). Both traces show fluctuating rolling velocities similar to 
the dotted trace. (B) Distance-time plots from the experi-
ments in A; solid line: in vitro leukocyte (calculated from the 
reported instantaneous velocity data); circles: the two in sil-
ico LEUKOCYTES from A.
Comparison of in vitro and in silico results for six different  experimental conditions Figure 9
Comparison of in vitro and in silico results for six dif-
ferent experimental conditions. The in vitro conditions 
(from [3]): the flow chamber surface was coated with P-
selectin and/or VCAM-1 with or without immobilized GRO-
α chemokine. The number of leukocytes that rolled and 
adhered within each of five fields of view were recorded for 
a 30-second observation interval. In vitro: white circles: aver-
age number of leukocytes that rolled; white squares: average 
number of leukocytes that adhered; error bars: ± 1 SD. The 
data are clustered and plotted for each of six conditions, as 
labeled. By using the parameter values in Table 5 (part III), 
the in silico experiments mimicked the in vitro experimental 
conditions and also the results: the results are averages from 
20 sets containing 30 LEUKOCYTES each; each simulation 
ran for 300 simulation cycles (equivalent to about 30 sec-
onds). In silico: dark circles: average LEUKOCYTES that 
ROLLED; dark squares: average LEUKOCYTES that 
ADHERED; error bars: ± 1 SD. Each light gray box contains 
the two sets of observations (in vitro and in silico) that 
should be compared.BMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
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rates of bond dissociation for ligands are too fast to be dis-
tinguished on our time-scale. Consequently, BONDS
experiencing larger forces are represented as having under-
gone a DISSOCIATION event during a simulation cycle
with a probability of 1.
Many molecular level details are believed to impact effec-
tive bond formation and breakage within small portions
of a leukocyte membrane and the surface. Examples
include contact irregularities, local dynamics, including
ligand relocation within the membrane, force history of
bond loading, and bond compliance. All are aggregated
and controlled in the ISWBC by an event probability.
When explanation of system level behaviors requires a
more detailed representation, one or more of these factors
can be specifically represented, without compromising
the function of other ISWBC components. The probability
parameters will remain, but their values and explanation
will have changed.
In the most recent version of their model, Hammer and
co-workers represent the p38 mitogen-activated protein
kinase (MAPK) global integrin activation mechanism
leading to leukocyte arrest induced by E-selectin engage-
ment with its ligand PSGL-1 [30]. A simple modular Hill
function is used to represent the overall MAPK cascade
leading to integrin activation. At the end of each time step,
the total number of E-selectin-PSGL-1 bonds are counted
and used as an input to this function. We have chosen to
explore an alternative integrin activation mechanism in
which detection of chemokines activates local integrins.
Future embodiments of this modeling effort may include
the E-selectin-dependent signaling pathway.
Recent experiments have shown that leukocyte rolling on
substrate-coated, flow chamber surfaces is significantly
slower and smoother than that of microspheres coated
with ligands [15,31]. It has been hypothesized that the
deformability of leukocytes can influence rolling by
increasing the contact area. In vivo, leukocytes rolling at
blood wall shear rates of 800 s-1 elongate in the direction
of flow to 140% of their estimated undeformed diameter
and have a 3.6-fold increased contact area with the
endothelium than at blood wall shear rates of 50 s-1 [32].
These experiments have influenced other modelers to
explore the mechanical and rheological properties that
influence leukocyte morphology and deformation. The 2-
D elastic ring model [33] and the 2-D compound drop
[34] model offer an account for the deformability of leu-
kocytes during rolling. However, because of the way
receptor-ligand interactions are treated deterministically,
these models do not produce the characteristic jerky stop-
and-go behavior of rolling leukocytes.
Recently, Jadhav et al. created a 3-D model that provides
a representation of leukocyte deformability: it can mimic
the stochastic nature of receptor-ligand interactions [35].
The model uses a mathematical formulation called the
Immersed Boundary Method to simulate the measured
motion of a leukocyte by representing it as an elastic cap-
sule in a linear shear field. They use a Monte Carlo
method for simulating receptor-ligand interactions, ena-
bling them to simulate the jerky stop-and-go movement
of rolling leukocytes. Their model explored the effects of
membrane stiffness on cell deformation and leukocyte
rolling. It is believed that the contact area between the sur-
face and the leukocyte membrane would increase for leu-
kocytes under increasing shear rates. By introducing
deformation in their model, they are able to observe this
change in contact area. Our model currently ignores this
phenomenon: we kept the contact area fixed for all simu-
lations. Future ISWBC descendents can, when needed,
allow each CELL to vary its own contact area.
Considerable knowledge has been gleaned from these dif-
ferent models of leukocyte rolling and adhesion. They
have provided insight into how molecular parameters of
adhesion molecules or cell deformability may influence
leukocyte rolling and adhesion. The knowledge gained
reinforces the merit of investigating complex phenomena
using different modeling methods. Our approach is quite
different and is aimed at studying the interactions of the
components and possible mechanisms that may give rise
to emergent leukocyte- and systems-level phenotypes.
Table 6: Calculated average ROLLING velocities, BONDS in the contact zone, and BONDS in the trailing row of the LEUKOCYTES' 
CONTACT ZONE
RearForce
0.1 0.2 0.3 0.4 0.5
Average ROLLING velocity (μm/s) 3.42 5.19 7.98 10.68 14.16
Average number of BONDS in CONTACT ZONE 7.26 6.42 5.45 4.87 4.29
Average number of BONDS in the rear row of LEUKOCYTES' CONTACT ZONE 1.5 1.46 1.40 1.38 1.33
Averages are from 60 simulations that had at least 10 INTERACTIONS (pauses). ROLLING velocities fall within ranges reported in the literature. 
Average number of BONDS in the CONTACT ZONE is in agreement with values estimated by mathematical models, which range from two to 
twenty bondsBMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
Page 17 of 25
(page number not for citation purposes)
Computational models of cell motility
Beyond the primarily mechanical models considered
above, what other modeling methods might one consider
to achieve the goal presented above under Setting the
Stage? Large-Q Potts models are based on extensions of
cellular automaton (CA) models [36], including lattice-
gas CA, with features adapted from the Ising model. They
have been used, for example, to study the cell sorting of
embryonic cells [37], and extended to simulate a variety of
different biological phenomena [38]. A further extension
using a layer for partial differential equations (describing
cAMP dynamics) enabled elegant simulations of the com-
plex cell movements occurring during culmination of the
morphogenesis of the slime mould Dictyostelium discoi-
deum [39]. Importantly, the simulated cells were repre-
sented as a group of connected automata making the basic
model scale subcellular. Important details of these meth-
ods are collectively reviewed by Alber et. al [40].
Such extended Potts models have been the preferred
approach for describing cell motility at a subcellular level,
including aspects of cell shape, surface chemistry, and
internal structure. Nevertheless, Meyer-Hermann and
Maini found it necessary to develop an alternative, agent-
oriented model architecture to interpret recent the two-
photon imaging data of lymphocyte movement within
lymph nodes [41]; the jerky and individualistic nature of
the imaging data is similar to that of leukocyte rolling.
They refer to their system as the hyphasma (the Greek
word for tissue) model.
The hyphasma LYMPHOCYTE is a connected collection of
subunit objects arranged on a 2D square grid centered on
Simulating experimental condition 2: rolling on VCAM-1 with shear increased at fixed intervals Figure 8
Simulating experimental condition 2: rolling on VCAM-1 with shear increased at fixed intervals. Alon et al. [17] 
observed T-lymphocytes rolling on VCAM-1 in the absence of chemokine under increasing wall shear stress; wall shear stress 
was increased at fixed intervals causing increased leukocyte rolling velocities. Black line: a leukocyte trajectory reported in 
[17]. Gray line: an example LEUKOCYTE trajectory when using ENVIRONMENT parameter values from Table 5 (part II). 
Insert: in vitro measures of leukocyte velocity for different values of shear (upper axis); the standard deviations (vertical bars) 
were conservatively estimated using the standard errors reported in [17]. Circles: average ROLLING velocities of LEUKO-
CYTES (n = 60) for different RearForce values (lower axis) fall within the in vitro ranges. The original published distance-time 
plots begin at ~140 microns.BMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
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Measurements from a LEUKOCYTE that ROLLED and ADHERED to PSELECTIN and VCAM1 after activation by GROA  CHEMOKINE Figure 10
Measurements from a LEUKOCYTE that ROLLED and ADHERED to PSELECTIN and VCAM1 after activa-
tion by GROA CHEMOKINE. Smith et al. [3] observed that when the flow chamber surface is coated with P-selectin and 
VCAM-1 co-immobilized with GRO-α chemokines, monocyte arrest occurred within a few seconds. The data graphed is from 
an in silico experiment that simulated that protocol and is for an individual LEUKOCYTE that transitioned from ROLLING to 
FIRM ADHESION (Table 5, part III). (A) Dark line: total number of BONDS formed within the CONTACT ZONE between 
LEUKOCYTE MEMBRANE and SURFACE. Light gray line: number of high affinity VLA4-VCAM1 BONDS formed: these results 
show that ADHESION is mediated primarily by the high affinity VLA4-VCAM1 BONDS. (B) DISTANCE-TIME plot and (C) 
VELOCITY-TIME plot: they show that the LEUKOCYTE rolled for less than a few simulated seconds before firmly adhering to 
the SURFACE, consistent with leukocyte adhesions observed in vitro. (D) For the same experiment, the number of low affinity 
VLA4-VCAM1 BONDS and PSELECTIN-PSGL1 BONDS are small and so are plotted here at a smaller scale. Dotted trace: 
number of low affinity VLA4-VCAM1 BONDS. Lower solid gray trace: number of BONDS formed between PSELECTIN and 
PSGL1. The black trace is a separate plot of the total number of BONDS formed at each time in the rear row of this CON-
TACT ZONE; these data show that for the ISWBC, the LOW AFFINITY VLA4/VCAM1 AND PSELECTIN/PSGL1 BONDS 
play only a minor role in supporting ADHESION. Arrows indicate when a LEUKOCYTE MEMBRANE SPREADING event 
occurred.BMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
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a virtual barycenter. Each one has a polarity vector, a list
of its constituent subunits, internal velocity states, and a
CELL volume that determines the number of subunits.
During movement, the barycenter is shifted in the direc-
tion of the polarity vector and border subunits are ran-
domly moved to lattice points near the newly established
barycenter. The simulated results exhibit Capability 4
(Turing Test) and support the hypothesis that lymphocyte
movement within secondary lymphoid tissue may not be
a consequence of chemotaxis or haptotaxis, but a simple
random walk. It seems likely that the hyphasma model
could be used to simulate data like that in Figures 5, 6, 7,
8. However, extending the model so that it delivers Capa-
bility 3 (Mapping) seems problematic. Relative to the
abstract nature of the subunits, the authors state: "a force
balance equation for the cell subunits is not necessarily a
correct description of active processes of deformation and
reshaping of cells. Thus, the interpretation of cell subunit
velocities in terms of forces has to be considered as an
approximation to more complex internal processes within
the cell." Simulating data like that in Figures 9 and 10 is
beyond hyphasma's current capabilities, but then the
model was not developed with the intent that it be adapt-
able and extensible to represent such data (Capabilities 5
and 8). As stated in Introduction, when developing the
ISWBC we had in mind objectives beyond simply simulat-
ing the in vitro data presented. We sought and presented
a method for assembling individual components (that
map to identifiable biological counterparts) according to
a design, and then showed that the constructed ISWBC can
exhibit behaviors that match those observed.
Future directions
The ISWBC described here is an important first step
towards our long-term goal of building in silico devices
that can simulate leukocyte behaviors in a variety of in
vitro experimental systems even in the face of considera-
ble uncertainty. They are useful objects for experimenta-
tion, as are the referent in vitro models. The current
ISWBC is capable of mimicking only a few (Table 1) of a
long list of desired phenotypic attributes of leukocytes
observed in vivo and in vitro. The expectation is that
ISWBCs can be iteratively refined to become increasingly
realistic in terms of both components and behaviors.
Because we strove to deliver the ten capabilities listed in
the Introduction, any of the above, abstract, low resolu-
tion components can be replaced with validated, more
realistic, higher resolution composite objects that map to
more detailed biological counterparts, without having to
reengineer the whole system, and without having to com-
promise already validated features and behaviors.
Methods
An in silico device
One of the best ways to understand a complex system is to
build a device, an analogue, which exhibits some of the
same behaviors. We cannot build scientifically useful cell-
like devices from inanimate organic components, but
because of advances in software engineering, we can build
cell-like devices in software. The in silico system described
below is such a device. It is a discrete event, discrete space,
and discrete time analogue of the entire in vitro parallel
plate flow chamber system sketched in Figure 2B. We used
the synthetic modeling method [42-45]. Object-oriented
software components were designed, verified, and then
plugged together in ways that were intended to represent
the modules, components, mechanisms, and processes
that are believed to influence leukocyte adhesion (or lack
thereof) and rolling in vitro. We have tried to keep the gap
between in silico mechanism and measured phenomena
as small as practicable. In so doing, we avoided getting too
complicated too soon. We have used the Recursive Porous
Agent Simulation Toolkit (RePAST) as our modeling and
simulation framework. It is a java-based software toolkit
developed at the University of Chicago for creating and
exercising agent-based models. The libraries provided are
used to create, run, display, and collect data. From within
the RePAST framework, the system described below can
operate in ways that represent the hypothesized mecha-
nisms and processes at the level of detail and resolution
needed simulate the targeted attributes (Sets A and B) in
Table 1.
In silico system components
The reliance on grids (Figures 2A and 11) in the details
that follow, where different locations can have different
properties, is reminiscent of CA. However, the ISWBC is
not a CA, nor is it similar to extensions of CA, such as
hybrid CA, lattice-gas CA, and Potts models. A CA [36]
consists of an infinite, regular grid of cells, each in one of
a finite number of states. The grid can be in any finite
number of dimensions. Time is discrete. The state of a cell
at time t is a function of the states of a finite number of
cells (its neighborhood) at time t-1. The neighborhood
does not change. Every cell has the same rule for updating,
based on the values in this neighborhood. Each time the
rules are applied to the whole grid a new generation is cre-
ated.
A CA is not a grid with several automata in it. The whole
collection, cells, logic, and data, constitute a single autom-
aton. This differs from the ISWBC, in which objects reside
and interact, and in which each agent can act autono-
mously (both within and between spaces) and, e.g., set
their own schedules and determine the other agents with
whom they will interact. A CA takes place on a regular grid
and has a fixed mediation space that is globally definedBMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
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and does not change. Extended CA, such as a hybrid CA,
might have several grids (or irregular grids, like a Voronoi
grid) that may come into play at different times.
Rather than attempt several extensions of the CA concept,
we draw on concepts used in object-orientation software
design and are built into agent-based modeling methods.
Object-orientation design (irrelevant of programming) is
the most natural technology in which to render an in-
depth analogous modeling relation. To achieve all ten
capabilities we need a multi-scale, hierarchical, discrete-
event, discrete-time, object-oriented, agent-based mode-
ling method that relies on message passing and partially
ordered sets of events for object interaction. By using the
minimal formalism of partially ordered sets, such a model
can maximize its expressibility and minimize artifacts that
may be caused by formalisms that are more restrictive,
such as CA and its extensions.
Each LEUKOCYTE is represented by an object (Figure 2A).
Models of leukocyte adhesion often assume that the
molecular interactions within the area of contact between
leukocytes and the substrate-coated surface are the only
relevant interactions during rolling and adhesion. We do
the same. We assume that, because of the required, locally
fast reaction times, all required intracellular processes
occur quickly, or are localized close to the membrane. We
assume that during rolling and adhesion, intracellular
processes work together to enable behaviors. Conse-
quently, for the attributes targeted, we treat intracellular
processes as being constant and MEMBRANE UNIT proc-
esses (defined below) as being autonomous.
We refer to that portion of a leukocyte membrane in con-
tact with the surface as the contact zone. Leukocyte mem-
brane functionality within the contact zone is
heterogeneously distributed. Some receptor types are con-
fined to microvilli tips, whereas others are found in the
spaces between. We discretized the leukocyte membrane
by subdividing the contact zone into arbitrary units of
functionality (hereafter, membrane unit). All of the func-
tionality within a membrane unit (signaling to and from
the cell interior, endocytosis, secretion, etc.) is aggregated,
and represented by the behavior of a MEMBRANE UNIT.
That behavior is an emergent property of the objects (or
agents) contained within (see Figure 2C). The granularity
of that subdivision need only be fine enough to represent
the targeted behaviors (Table 1). Because of having speci-
fied the articulate and granular capabilities (5 and 6: Intro-
duction), it was easy to increase or decrease subdivision
granularity.
Because the targeted attributes involve only the contact
zone, only events that specifically influence those behav-
iors are represented. Other aspects of membrane dynam-
ics and molecular biology are not ignored. They are
simply not among the system aspects on which we have
focused in this project. Any of them can be brought into
focus when needed by adding one or more new compo-
nents to each MEMBRANE UNIT, and that can be done
without having to completely reengineer the ISWBC.
There are currently only three objects within each MEM-
BRANE UNIT: one to represent the functionality of each of
the three different leukocyte membrane ligands: PSGL-1
ligand, VLA-4 integrin, and CXCR-2 chemokine receptor.
Each of these objects is an agent3.
For convenience and simplicity, we represent the contact
zone using an arrangement of MEMBRANE UNITS in a
uniform grid (Figure 2A), and refer to it as the CONTACT
ZONE. A MEMBRANE UNIT within the CONTACT ZONE
maps to an arbitrary portion of membrane that is in con-
tact with the surface, and may include the tethers that are
known to form between rolling leukocytes and surfaces
[46]. Leukocytes have stretchy microvilli and are highly
irregular in shape [46-48]. Consequently, the precise area
of membrane-surface contact during rolling is uncertain.
We reflect that uncertainty by specifying that MEMBRANE
UNITS are changeable, and by not specifying a mapping
between a MEMBRANE UNIT and a precise amount of
membrane area. However, the mapping between MEM-
BRANE UNIT and distance rolled is important: that is dis-
cussed below under Behavior. The balance of the
LEUKOCYTE'S surface outside the CONTACT ZONE is
assumed a reservoir of MEMBRANE UNITS. For program-
ming convenience, we represented that reservoir as an
extension of the CONTACT ZONE, as illustrated in Figure
2A, that has grid dimensions 5–10 times that of the size of
CONTACT ZONE. Hereafter, we refer to the entire grid as
the MEMBRANE. To accommodate MEMBRANE mobility
relative to the SURFACE, the MEMBRANE at the software
level is a 2D toroidal lattice.
The number of MEMBRANE UNITS within the CONTACT
ZONE can be easily increased or decreased. The observed
ratio of length to width of rolling rat leukocytes in vivo is
approximately 1.25-1.5 [47] over a range of shear values.
We assumed that rat and human leukocytes deform simi-
larly, and therefore represented the contact zone using a
rectangular grid with width-to-length dimensions having
a similar ratio. All simulations in this report represent the
CONTACT ZONE using an 8 × 10 arrangement of MEM-
BRANE UNITS. That resolution (level of granularity) was
selected after experimenting with coarser and finer repre-
sentations. Larger granularities failed to exhibit the tar-
geted behaviors4 (within a factor of two or better). Smaller
granularities failed to improve simulation results. For two
reasons, we did not optimize CONTACT ZONE size. First,
we have not yet developed a means of determining pre-
cisely which of two similar behaving but differentlyBMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
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parameterized simulations is the closer match over a
range of in vitro measures (such as Figures 5, 6, 7, 8). Sec-
ond, LEUKOCYTE behavior also depends on the nature
and specification of the components within (discussed
below).
A portion of the bottom flow chamber surface is repre-
sented by the SURFACE SPACE (hereafter simply SUR-
FACE). SURFACE functionality was also subdivided. In
each simulation, its granularity matches that of the MEM-
BRANE, as illustrated in Figure 2A: one unit of SURFACE
corresponds to about 1 μm2. That grid is also a 2D toroi-
dal lattice. As with the MEMBRANE, each unit of SUR-
FACE function is represented by a container object, called
a SURFACE UNIT, one per grid space. Contained within
each SURFACE UNIT are agents representing the substrate
molecules (P-selectin, VCAM-1, and GRO-α chemokine)
for the three leukocyte membrane ligands listed in Tables
2 and 3.
Agents contained within MEMBRANE UNITS and SUR-
FACE UNITS are of the class type LIGAND. A LIGAND
agent represents a group of binding molecules of the same
type that may be found within a portion of the membrane
or flow chamber surface. For example, a PSGL1 represents
several PSGL-1 adhesion molecules. The number repre-
sented is illustrated by the numbers assigned to the
objects within each MEMBRANE UNIT in Figure 2C. The
actual number represented is determined by the parame-
ter TotalNumber. At the beginning of each simulation, its
value is uniquely determined according to the values of
DensityMean and DensitySTDev. Figure 11 shows the Total-
Number values of the PSGL1 for two MEMBRANES used
during a simulation. The targeted behaviors were achieved
using random assignment of values to each PSGL1 and
VLA4 agent. Particular patterns of ligands within the con-
tact zone, such as regions of high and low PSGL-1 densi-
ties can also be implemented when required by targeted
behaviors.
Table 3 shows LIGANDS sub-classed as ADHESION MOL-
ECULES, CHEMOKINE RECEPTORS, and CHEMOK-
INES, corresponding to adhesion molecules, chemokine
receptors, and chemokines, respectively. In addition,
there is a sub-class of ADHESION MOLECULES called
INTEGRINS. INTEGRINS are different from the other LIG-
ANDS in that they have two sets of parameters, one repre-
sents a low, and another represents a high affinity state.
All INTEGRINS are initially in the low affinity state.
Events within the CONTACT ZONE (see below) deter-
mine if, and when, an INTEGRIN is converted to the high
affinity state.
For each ligand type, on either the chamber surface or leu-
kocyte membrane, there can be a corresponding LIGAND
agent within the container object at each SURFACE and
MEMBRANE grid location. We have set a maximum value
of one LIGAND of each type at all locations. Table 2 lists
each of the ligands in the model, the LIGAND objects that
represent them, their LIGAND class type, and their loca-
tion within the ISWBC.
Behaviors
During each simulation, the CONTACT ZONE portion of
the MEMBRANE is positioned "above" the SURFACE so
that LIGANDS in overlapping MEMBRANE and SURFACE
UNITS can "see" and interact with each other (Figure 2A)
and form BONDS.
When the bonds on tethers and other points of contact are
broken at the rear of a rolling leukocyte under the influ-
ence of shear, the leukocyte ratchets forward some dis-
tance (until sufficient new bonds are formed, as discussed
below). The ISWBC works analogously. If there are no
BONDS within the rear row of the CONTACT ZONE, the
LEUKOCYTE ratchets forward (north) until the rear row
contains at least one BOND during the simulation cycle.
Ratcheting involves removing a row of MEMBRANE
UNITS from the rear of the CONTACT ZONE while a new
row is placed at the front. Thus, the location of the CON-
TACT ZONE on the MEMBRANE and its position "over"
the SURFACE changes whereas CONTACT ZONE dimen-
sions are kept constant (Fig 3A). During a single simula-
tion cycle, a ratchet movement can be repeated up to nine
times (for a LEUKOCYTE with a CONTACT ZONE length
of 10 MEMBRANE UNITS). Currently, only forward
(north) movement is permitted. However, we can enable
east or west rolling-like movements when that is needed.
We have also implemented SURFACE boundary condi-
tions in order to reduce the number of simulated SUR-
FACE UNITS. A LEUKOCYTE ROLLING off any edge will
continue ROLLING at the opposite edge. This feature has
reduced computational time and simplified visualization.
We assume that each ratchet movement maps, on average,
to a leukocyte having moved 1 μm. If the data were avail-
able to support doing so, the mapping between each for-
ward ratchet and relative distance moved could be drawn
from a distribution having a mean of ~1 μm and some
specified variance. By so doing, we may represent some of
the real uncertainty associated with in vitro measures.
However, the data are not yet available. For simplicity, we
fixed the mapping to be 1 μm. If the mapping between a
simulation cycle and in vitro time is changed, then this
distance mapping too must change.
Components have been designed to facilitate changing
CONTACT ZONE dimensions dynamically during a sim-
ulation. It is believed that leukocyte deformation supports
firm adhesion by increasing the zone of contact, therebyBMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
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allowing formation of more adhesive bonds. If a LEUKO-
CYTE remains ADHERENT for at least 100 simulation
cycles, an extra row is added at the front and an extra col-
umn is added along one side (selected randomly) of the
CONTACT ZONE allowing additional BONDS to form.
This process mimics spreading and helps stabilize ADHE-
SION.
During each simulation cycle, each LIGAND within the
CONTACT ZONE has one opportunity to form and break
BONDS. However, only BONDS at the rear row of the
CONTACT ZONE experience the effects of the SHEAR
FORCE (described below). Only when all BONDS at the
rear have been BROKEN can a LEUKOCYTE ROLL. If at
any time (during any simulation cycle), there are no intact
BONDS within the CONTACT ZONE, the LEUKOCYTE
removes itself from the SURFACE and the simulation
ends, mimicking a leukocyte detaching and being swept
away by the fluid flowing through the chamber. Figure 3
outlines the programmed decisional processes that deter-
mine the flow of events within each simulation cycle.
Forming and Breaking BONDS Between ADHESION 
MOLECULES
When a LEUKOCYTE LIGAND encounters its binding
partner on an overlapped SURFACE UNIT, it first deter-
mines the theoretical maximum number of BONDS that
can be formed (defined below). A Monte Carlo algorithm
is then used to determine the actual number of BONDS
that form. Each simulated adhesion molecule type uses
the values of three parameters to determine BOND-for-
mation with its binding partner: 1) TotalNumber specifies
the number of receptors. The smaller of the two TotalNum-
ber parameters is used during calculations of the theoreti-
cal maximum. 2) BondNumber specifies the number of
BONDS that already have been formed between the LIG-
AND pair. The theoretical maximum number of BONDS
is simply the difference between these two values. 3) Pon
is the probability of bond formation for each binding
pair. Pon was fixed at 0.001, 0.001, and 0.005 for PSGL-
PSELECTIN, low affinity VLA4-VCAM1, and high affinity
VLA4-VCAM1 BONDS, respectively.
For each potential BOND, Pon is compared to a pseudo-
random number between 0 and 1 to determine if the
BOND is actualized. Pon is fixed for the duration of a sim-
ulation. For the INTEGRINS that represent ligands with
high affinity states, this process is repeated separately
using parameter values corresponding to the higher affin-
ity state.
The effect of shear on the rear of a leukocyte is represented
by the variable RearForce. BONDS experience a bondforce
that is calculated each simulation cycle by dividing the
RearForce by the total number of BONDS in the rear row
of the CONTACT ZONE. Bonds within the rest of the
CONTACT ZONE experience no bondforce. Drawing from
the in vitro data discussed below, we have assumed the
simple linear relationship between bondforce  and the
probability of BOND dissociation shown in Figure 4A. It
is calculated as (probability of dissociation) = b0 + (bond-
force) × b1, where b1 and b0 are the slope and intercept,
respectively, of the line segment associated with a specific
bondforce. Each type of simulated adhesion molecule pair
uses a unique set of b0 and b1 values obtained from Figure
4A. Each relationship is intended to be an analogue of the
force dependence of dissociation rates for P-selectin/
PSGL-1 bonds reported by Park et al. [15], and those of
high affinity VLA-4/VCAM-1 bonds reported by Zhang et
al. [29] (Figure 4B). The bondforce relationships in Figure
4A are not intended to match or precisely fit in vitro data.
Doing so would require that we specify the relationship
between wet-lab measures of bond force and our in silico
parameter bondforce. There is neither need nor reason to
do so at this early stage of analogue development.
Park et al. calculated PSGL-1/P-selectin dissociation rates
as a function of force experienced by the bond by observ-
ing PSGL-1 covered microbeads rolling on P-selectin sub-
strate in a parallel plate flow chamber. For the range of
dissociation rate constants relevant to this report (Koff val-
ues < 10/s), the in vitro data, as shown in Figure 4B, is
close to linear (the values in Figure 4B were calculated
from the reported, best fit values [15]). The unstressed dis-
sociation constant, K0off, for PSGL-1/P-selectin bonds
were calculated to be 1.6/s.
Zhang et al. used single-molecule dynamic force spectros-
copy to investigate the strength of the VLA-4/VCAM-1
complex. The experimental conditions were not the same
as in vitro. Nevertheless, the relative behavior of the VLA-
4/VCAM-1 complex is expected to be similar to that in the
flow chamber. The dissociation of the VLA-4/VCAM-1
complex was determined to involve overcoming two acti-
vation energy barriers. Under pulling forces < ~50 pN, dis-
sociation rates were governed principally by the properties
of the outer activation energy barrier. The K0off values for
the outer energy barriers for the low- and high-affinity
complexes were 1.4/s and 0.0035/s, respectively. The high
affinity data in Figure 4B were converted from the
reported semi-log plots [29]. The force dependence of dis-
sociation rate for low affinity VLA-4/VCAM-1 was not
reported. We assumed that it is similar to PSGL-1/P-selec-
tin, and represented it so in Figure 4A.
Activation
A LEUKOCYTE that is interacting with the SURFACE uses
CHEMOKINE RECEPTORS to detect any CHEMOKINE
object that may be present. As a simplification (and
because each simulation cycle is long compared to chem-BMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
Page 23 of 25
(page number not for citation purposes)
okine binding and dissociation), we specified Pon and Poff
values of 1.0 for CHEMOKINE RECEPTORS such that
each detected CHEMOKINE can BIND and DISSASOCI-
ATE (i.e., the events are registered as having been
detected) within the same simulation cycle. Conse-
quently, CHEMOKINES can be detected by the same
RECEPTOR during different simulation cycles. For each
CHEMOKINE detected, a message is sent to the
INTEGRIN within that MEMBRANE UNIT to decrement
the low affinity TotalNumber parameter and increment the
high affinity TotalNumber parameter. If low affinity Total-
Number reaches 0, then the activation mechanism for that
INTEGRIN is turned off.
A maximum of approximately 10% of β-2 integrins on a
leukocyte membrane become induced into high affinity
states when exposed to chemokines [49]. We have
assumed that the VLA-4 integrin has similar properties.
When the sum of the TotalNumber  high affinity state
parameters from all INTEGRINS within the MEMBRANE
exceeds 12.5% of the sum of the TotalNumber high and
low affinity values from all the INTEGRINS, the activation
mechanism is turned off for all INTEGRINS. The above
representation of the chemokine dynamics is a simple,
abstract metaphor for a complex phenomenon. Future
ISWBC descendants will include representations of chem-
okine binding and signaling dynamics that are more real-
istic.
Software
The ISWBC software and support documentation is avail-
able at [58].
Appendix
Footnotes
1 Replacing an object within the model with a collection
of subunit objects that still give rise to the original object
behavior is an example of increasing model level. See [13]
for a discussion of hierarchical, modular modeling meth-
ods, and [14] for a review of the related topic of multi-
scale models.
2 When we increase or decrease the number of grid points
in the CONTACT ZONE, we are changing granularity.
That has no impact on the number of model levels.
3 Technically, an agent is a software object (either atomic
or composite) with the ability to interact with its environ-
ment and schedule its own actions.
4 An example of an unacceptable behavior was too fre-
quent detachment. If we make the properties and behav-
iors of the components within a MEMBRANE UNIT more
complicated, we can get similar behaviors from a contact
area comprised of fewer units. However, a goal is to keep
component objects as simple as possible.
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Contour plots show the number of PSGL-1 molecules repre- sented by a MEMBRANE UNIT Figure 11
Contour plots show the number of PSGL-1 mole-
cules represented by a MEMBRANE UNIT. The 
number of PSGL-1 represented are shown for two different 
LEUKOCYTE MEMBRANES. Each of the 600 MEMBRANE 
UNITS within each MEMBRANE contains one PSGL1 agent 
(see Figure 2C). Each PSGL1 TotalNumber parameter value 
(indicated by the scale on the right) specifies the number of 
PSGL-1 molecules represented in a specified MEMBRANE 
UNIT. When averaged over the entire MEMBRANE, a typical 
PSGL1 represents 150 ± 5 PSGL-1 (see Table 3). The 8 × 10 
region outlined in white is the CONTACT ZONE. Arrows 
specify the row of MEMBRANE UNITS (at the "rear" of the 
CONTACT ZONE) that experiences RearForce, when the 
LEUKOCYTE is moving from right to left.BMC Systems Biology 2007, 1:14 http://www.biomedcentral.com/1752-0509/1/14
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